{"id":7117,"date":"2024-02-03T23:46:25","date_gmt":"2024-02-03T22:46:25","guid":{"rendered":"https:\/\/genetika-plzen.nullable.group\/?page_id=7117"},"modified":"2024-04-24T00:14:36","modified_gmt":"2024-04-23T22:14:36","slug":"screening-v-tehotenstvi","status":"publish","type":"page","link":"https:\/\/genetika-plzen.nullable.group\/en\/geneticka-ambulance\/screening-v-tehotenstvi\/","title":{"rendered":"Screening examinations"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

I.trimester<\/h2><\/h2><\/section><\/div><\/main><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tFirst trimester screening is performed when the fetus is between 11 weeks + 3 days and 13 weeks + 6 days old, with a crown-rump length (CRL) of 45-84 mm. At this stage of pregnancy, it is possible to diagnose certain congenital organ defects and assess so-called ultrasound markers for fetal diseases. An important feature is the swelling of the skin in the neck area (nuchal translucency \u2013 NT). Significant enlargement of NT may indicate a risk of congenital defects. It is also important to assess other signs such as the presence of the nasal bone (NB), tricuspid regurgitation, and ductus venosus. This examination also includes a maternal blood test to determine the levels of placental hormones and proteins, PAPP-A and free \u03b2hCG. Based on these examinations, the combined risk of chromosomal abnormalities for the fetus, especially Down, Edwards, and Patau syndromes, is determined.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tYOU CAN HAVE THE SCREENING RESULT AT OUR DEPARTMENT ON THE SAME DAY.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t
Combined first trimester screening including preeclampsia \u2013 genetic risk assessment \u2013 singleton pregnancy<\/td>\n\t\t\t\t\t\t2 000 K\u010d<\/td>\n\t\t\t\t\t<\/tr>\n\t\t\t\t\t
Combined first trimester screening including preeclampsia \u2013 genetic risk assessment \u2013 twins<\/td>\n\t\t\t\t\t\t3 000 K\u010d<\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Preeclampsia screening<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tPreeclampsia is a condition that occurs only during pregnancy and is characterized by a triad of symptoms \u2013 increased blood pressure, significant protein loss in the urine, and generalized swelling. This condition manifests after the 20th week of pregnancy and in the most severe cases can lead to the induction of preterm birth or termination of pregnancy by cesarean section, which can be associated with serious complications for the newborn. Unfortunately, it can also pose a threat to the health and life of the mother. The test to determine the risk of preeclampsia is performed simultaneously with the combined first trimester screening and has a detection rate of up to 90%. Performing this test is recommended for all pregnant women.\n\n

The test has three parts:<\/p>\n\n